NATCO PHARMA LTD. - 524816 - Proceedings Of The 40Th Annual General Meeting
Proceedings of the 40th Annual General Meeting held on 29th September, 202329-09-2023
29-09-2023
NATCO Pharma faces antitrust lawsuit in the US, shares dip
The lawsuit revolves around Pomalidomide (POMALYST), a pharmaceutical product11-09-2023
Natco Pharma, others sued in US for generic cancer drug
The company believes this matter is without merit, Natco Pharma said in a statement.08-09-2023
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of confirmation of duplicate share certificate07-09-2023
NATCO PHARMA LTD. - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ananda Babu T & Anila T06-09-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publications06-09-2023
NATCO PHARMA LTD. - 524816 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the Financial Year ended 31st March, 202304-09-2023